Who Supplies Mycophenolate? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Mycophenolate exports, with 167+ registered manufacturers shipping to buyers across 100+ countries — yet a handful of companies dominate the shipments. INTAS PHARMACEUTICALS LIMITED holds the largest share at 56.0% (export value: $187.2M). Close behind, STRIDES PHARMA SCIENCE LIMITED (8.7%, $29.2M). ALKEM LABORATORIES LIMITED (4.3%, $14.4M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Mycophenolate? Top Manufacturers & Their Buyers
Flow of Mycophenolate from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Mycophenolate Supplier Network — Key Market Intelligence
The Mycophenolate export market from India is led by INTAS PHARMACEUTICALS LIMITED, which alone commands a 56.0% share, shipping $187.2M worth of product across 454 shipments. The second-largest exporter, STRIDES PHARMA SCIENCE LIMITED, contributes $29.2M (8.7%) to the overall market. Combined, the top two suppliers alone account for 64.7% of all Mycophenolate exports, indicating a relatively concentrated supply base.
Across all 167 tracked manufacturers, the total Mycophenolate export value stands at $334.4M from 2.5K shipments. The market average shipment value is $132.2K. The single largest buyer relationship in terms of trade value is EVERSANA LIFE SCIENCES SERVICES LLC, receiving $166.8M worth of product.
The combined buyer network spans 16 named purchasing companies, including EVERSANA LIFE SCIENCES SERVICES LLC, APOTEX PTY LTD, I & C (HONGKONG) LIM, STRIDES PHARMA INC,, AVET PHARMACCEUTICALS INC and 11 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1INTAS PHARMACEUTICALS LIMITED
INTAS PHARMACEUTICALS LIMITED is the first-largest Mycophenolate exporter from India, with a market share of 56.0% and a total export value of $187.2M across 454 shipments. Their average shipment value of $412.3K is above the market average of $132.2K, suggesting premium or bulk contract pricing.
INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. EVERSANA LIFE SCIENCES SERVICES LLC is the dominant customer, accounting for 89.1% of this supplier's tracked business. Top customers include:
• EVERSANA LIFE SCIENCES SERVICES LLC — $166.8M across 404 shipments (89.1% of this supplier's total exports)
• APOTEX PTY LTD — $12.6M across 31 shipments (6.7% of this supplier's total exports)
• I & C (HONGKONG) LIM — $3.5M across 8 shipments (1.9% of this supplier's total exports)
• EVERSANA LIFE SCIENCES SERVICES LLC — $2.6M across 6 shipments (1.4% of this supplier's total exports)
• EVERSANA LIFE SCIENCES SERVICES LLC — $1.7M across 4 shipments (0.9% of this supplier's total exports)
Key Insight: INTAS PHARMACEUTICALS LIMITED's per-shipment value of $412.3K is 212% above the market average of $132.2K, consistent with large-order contracts or value-added formulations.
2STRIDES PHARMA SCIENCE LIMITED
STRIDES PHARMA SCIENCE LIMITED is the second-largest Mycophenolate exporter from India, with a market share of 8.7% and a total export value of $29.2M across 193 shipments. Their average shipment value of $151.5K is above the market average of $132.2K, suggesting premium or bulk contract pricing.
STRIDES PHARMA SCIENCE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• STRIDES PHARMA INC, — $13.9M across 92 shipments (47.4% of this supplier's total exports)
• STRIDES PHARMA INC, — $9.7M across 64 shipments (33.1% of this supplier's total exports)
• AVET PHARMACCEUTICALS INC — $2.7M across 18 shipments (9.4% of this supplier's total exports)
• AVET PHARMACCEUTICALS INC — $1.8M across 12 shipments (6.3% of this supplier's total exports)
• STRIDES PHARMA INC, — $1.1M across 7 shipments (3.8% of this supplier's total exports)
Key Insight: STRIDES PHARMA SCIENCE LIMITED's per-shipment value of $151.5K is 15% above the market average of $132.2K, consistent with large-order contracts or value-added formulations.
3ALKEM LABORATORIES LIMITED
ALKEM LABORATORIES LIMITED is the third-largest Mycophenolate exporter from India, with a market share of 4.3% and a total export value of $14.4M across 356 shipments. Their average shipment value of $40.6K is below the market average of $132.2K, reflecting a high-volume, competitive pricing strategy.
ALKEM LABORATORIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• ASCEND LABORATORIES,LLC — $6.0M across 147 shipments (41.4% of this supplier's total exports)
• ASCEND LABORATORIES,LLC — $3.9M across 97 shipments (27.3% of this supplier's total exports)
• ASCEND GMBH — $2.2M across 54 shipments (15.2% of this supplier's total exports)
• PHARMACOR PTY LTD — $1.2M across 30 shipments (8.3% of this supplier's total exports)
• ASCEND LABORATORIES LLC — $1.1M across 28 shipments (7.8% of this supplier's total exports)
Key Insight: ALKEM LABORATORIES LIMITED operates with high shipment frequency (356 shipments) at a per-shipment value of $40.6K, indicating a broad distribution network with many smaller, regular orders.
4SANDOZ PRIVATE LIMITED
SANDOZ PRIVATE LIMITED is the fourth-largest Mycophenolate exporter from India, with a market share of 4.0% and a total export value of $13.3M across 204 shipments. Their average shipment value of $65.2K is below the market average of $132.2K, reflecting a high-volume, competitive pricing strategy.
SANDOZ PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• SANDOZ INC C O EXEL INC — $6.3M across 97 shipments (47.5% of this supplier's total exports)
• SANDOZ INC C O EXEL INC — $5.0M across 77 shipments (37.9% of this supplier's total exports)
• SANDOZ INC C O EXEL INC — $763.0K across 12 shipments (5.7% of this supplier's total exports)
• SANDOZ PTY LTD — $663.3K across 10 shipments (5.0% of this supplier's total exports)
• SANDOZ CANADA INC C — $515.8K across 8 shipments (3.9% of this supplier's total exports)
Key Insight: SANDOZ PRIVATE LIMITED operates with high shipment frequency (204 shipments) at a per-shipment value of $65.2K, indicating a broad distribution network with many smaller, regular orders.
5EMCURE PHARMACEUTICALS LIMITED
EMCURE PHARMACEUTICALS LIMITED is the fifth-largest Mycophenolate exporter from India, with a market share of 2.7% and a total export value of $9.0M across 299 shipments. Their average shipment value of $30.2K is below the market average of $132.2K, reflecting a high-volume, competitive pricing strategy.
EMCURE PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• TILLOMED LABORATORIES LTD. — $3.0M across 99 shipments (33.0% of this supplier's total exports)
• TILLOMED ITALIA SRL — $2.8M across 93 shipments (31.2% of this supplier's total exports)
• TILLOMED LABORATORIES LTD. — $1.7M across 56 shipments (18.7% of this supplier's total exports)
• TILLOMED LABORATORIES LTD. — $1.0M across 35 shipments (11.6% of this supplier's total exports)
• EMCURE PHARMA CHILE — $495.6K across 16 shipments (5.5% of this supplier's total exports)
Key Insight: EMCURE PHARMACEUTICALS LIMITED operates with high shipment frequency (299 shipments) at a per-shipment value of $30.2K, indicating a broad distribution network with many smaller, regular orders.
6CONCORD BIOTECH LIMITED
CONCORD BIOTECH LIMITED is the fifth-largest Mycophenolate exporter from India, with a market share of 1.9% and a total export value of $6.5M across 119 shipments. Their average shipment value of $54.4K is below the market average of $132.2K, reflecting a high-volume, competitive pricing strategy.
CONCORD BIOTECH LIMITED serves 5 named buyers in our database. TO THE ORDER is the dominant customer, accounting for 76.8% of this supplier's tracked business. Top customers include:
• TO THE ORDER — $5.0M across 91 shipments (76.8% of this supplier's total exports)
• NA — $454.9K across 8 shipments (7.0% of this supplier's total exports)
• CARITAS PHARMA S A D — $434.2K across 8 shipments (6.7% of this supplier's total exports)
• EVERSANA LIFE SCIENCES SERVICES LLC — $349.7K across 6 shipments (5.4% of this supplier's total exports)
• TO THE ORDER — $263.6K across 5 shipments (4.1% of this supplier's total exports)
Key Insight: CONCORD BIOTECH LIMITED operates with high shipment frequency (119 shipments) at a per-shipment value of $54.4K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Mycophenolate Flows
Once Mycophenolate leaves the manufacturing plants of companies like INTAS PHARMACEUTICALS LIMITED and STRIDES PHARMA SCIENCE LIMITED, it travels to 5 destination markets with a combined import value of $334.4M. United States absorbs the largest share at 76.6% ($256.2M), followed by Australia (6.1%) and United Kingdom (3.9%).
In United States — the top destination — named importers include EVERSANA LIFE SCIENCES SERVICES,LLC, STRIDES PHARMA INC,, STRIDES PHARMA INC. In Australia, key buyers are APOTEX PTY LTD, SANDOZ PTY LTD.
This geographic spread reflects Mycophenolate's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Mycophenolate Go? Top Importing Countries & Their Buyers
Trade flow of Mycophenolate exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Mycophenolate imports from India, with a total trade value of $256.2M across 596 shipments — representing a 76.6% share of all Mycophenolate exports. The average shipment value of $429.8K is above the global average of $132.2K, indicating high-value procurement contracts or branded formulations. This market is served by 10 tracked buyers.
Named Mycophenolate importers in United States: EVERSANA LIFE SCIENCES SERVICES,LLC is the largest buyer, accounting for 66.7% ($170.9M) of this market's total imports.
• EVERSANA LIFE SCIENCES SERVICES,LLC — $170.9M (66.7% of United States's total)
• STRIDES PHARMA INC, — $13.9M (5.4% of United States's total)
• STRIDES PHARMA INC — $13.8M (5.4% of United States's total)
Key Insight: United States's per-shipment average of $429.8K (225% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Mycophenolate imports from India.
2Australia
Australia ranks as the second-largest destination for Mycophenolate imports from India, with a total trade value of $20.5M across 25 shipments — representing a 6.1% share of all Mycophenolate exports. The average shipment value of $819.2K is above the global average of $132.2K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Mycophenolate importers in Australia: APOTEX PTY LTD is the largest buyer, accounting for 62.1% ($12.7M) of this market's total imports.
• APOTEX PTY LTD — $12.7M (62.1% of Australia's total)
• SANDOZ PTY LTD — $1.8M (8.6% of Australia's total)
Key Insight: Australia's per-shipment average of $819.2K (519% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Australia is a key market for Mycophenolate imports from India.
3United Kingdom
United Kingdom ranks as the third-largest destination for Mycophenolate imports from India, with a total trade value of $13.0M across 109 shipments — representing a 3.9% share of all Mycophenolate exports. The average shipment value of $119.6K is below the global average of $132.2K, consistent with generic/API volume purchasing. This market is served by 2 tracked buyers.
Named Mycophenolate importers in United Kingdom: TILLOMED LABORATORIES LTD is the largest buyer, accounting for 29.8% ($3.9M) of this market's total imports.
• TILLOMED LABORATORIES LTD — $3.9M (29.8% of United Kingdom's total)
• TILLOMED LABORATORIES LTD. — $2.1M (16.0% of United Kingdom's total)
Key Insight: United Kingdom receives frequent, smaller shipments of Mycophenolate — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
United Kingdom is a key market for Mycophenolate imports from India.
4Italy
Italy ranks as the fourth-largest destination for Mycophenolate imports from India, with a total trade value of $4.4M across 51 shipments — representing a 1.3% share of all Mycophenolate exports. The average shipment value of $86.4K is below the global average of $132.2K, consistent with generic/API volume purchasing. This market is served by 1 tracked buyer.
Named Mycophenolate importers in Italy: TILLOMED ITALIA SRL is the largest buyer, accounting for 79.0% ($3.5M) of this market's total imports.
• TILLOMED ITALIA SRL — $3.5M (79.0% of Italy's total)
Key Insight: Italy receives frequent, smaller shipments of Mycophenolate — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
Italy is a key market for Mycophenolate imports from India.
5Brazil
Brazil ranks as the fifth-largest destination for Mycophenolate imports from India, with a total trade value of $4.1M across 19 shipments — representing a 1.2% share of all Mycophenolate exports. The average shipment value of $218.3K is above the global average of $132.2K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Mycophenolate importers in Brazil: ACCORD FARMACUTICA LTDA is the largest buyer, accounting for 53.1% ($2.2M) of this market's total imports.
• ACCORD FARMACUTICA LTDA — $2.2M (53.1% of Brazil's total)
Key Insight: Brazil's per-shipment average of $218.3K (65% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Brazil is a key market for Mycophenolate imports from India.
People Also Ask — Mycophenolate Supplier & Trade Network
Who are the top suppliers of Mycophenolate from India?+
Which companies buy Mycophenolate from Indian manufacturers?+
Where does Mycophenolate exported from India go?+
What is the market share of the top Mycophenolate supplier from India?+
What is the average shipment value for Mycophenolate exports from India?+
Is Mycophenolate manufactured in India and exported globally?+
Which country imports the most Mycophenolate from India?+
Who are the buyers of Mycophenolate in Australia?+
How concentrated is the Mycophenolate supplier market in India?+
How do I find verified buyers for Mycophenolate in specific countries?+
Mycophenolate Trade Network — Key Takeaways
- 1INTAS PHARMACEUTICALS LIMITED is India's dominant Mycophenolate exporter with a 56.0% market share and $187.2M in total exports — making it the single most important sourcing entity in this market.
- 2The top 167 suppliers collectively account for 77.6% of all tracked Mycophenolate exports, with a combined trade value of $334.4M.
- 3United States is the largest destination market, absorbing 76.6% of India's Mycophenolate exports ($256.2M). Australia (6.1%) and United Kingdom (3.9%) follow.
- 4With 2.5K total shipments averaging $132.2K each, the Mycophenolate export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include EVERSANA LIFE SCIENCES SERVICES LLC, APOTEX PTY LTD, STRIDES PHARMA INC,, STRIDES PHARMA INC, — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 100 countries
Network value: $334.4M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Mycophenolate — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Mycophenolate.
- 2.Flow Mapping: 167 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 2,529 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 100 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,529 Verified Shipments
167 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists